Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06241274

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

This study was a prospective, multicenter, single-arm clinical study planned to enroll 60 patients who developed hemorrhagic cystitis after sexually allogeneic hematopoietic stem cell transplantation Patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation were given symptomatic supportive treatment combined with moxibustion covering Shenque, Zhongguo, Guanyuan, and Qihai for 30 minutes every day for 14 days and urine routine was collected every day for 14 days to assess the severity of hemorrhagic cystitis and pain scores to evaluate the effectiveness of moxibustion in treating hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Moxibustion Cystitis Cystitis, Hemorrhagic Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Hematopoietic Stem Cell Transplantation Hemorrhagic Cystitis Male Urogenital Diseases Treatment Urinary Bladder Diseases Urogenital Diseases Urologic Diseases

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yi Zhang

Wuhan, Hubei, 430000, China

Location status: Recruiting

Location contact

Yi Zhang

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients were fully aware of the study, participated voluntarily, and signed the informed consent form;
  • Age: 18-55 years old;
  • patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation;

Exclusion criteria

  • refusal to participate in this clinical study;
  • broken or sensitized skin corresponding to the moxibustion site;
  • allogeneic hematopoietic stem cell transplantationpatients pretreated with the Reduced-intensity conditioning.

Treatment and study plan

moxibustion

Other

Subjects received moxibustion covering Shenque, Zhonggong, Guanyuan, and Qihai for 30 minutes every day for 14 days.

Symptomatic supportive treatment

Other

Symptomatic supportive treatment.

Primary outcomes

  1. Core Lower Urinary Tract Symptom Score

    Time frame: 14 days

    The Core Lower Urinary Tract Symptom Score consists of 10 questions. Frequent daytime urination---0 points:<7 times;1 point:8~9 times;2 points:10~14 times;3 points:> 14 times. Nocturia---0 points:0 times/night;1 point:1 time/night;2 points: 2~3 times/night;3 points:> 3 times/night. The other 8 problems were urgency, dysuria, hesitancy, thin urine line, urge incontinence, stress incontinence, bladder pain, and urethral pain, which were rated as 0, 1, 2, and 3 according to their frequency (never, rarely, sometimes, and often).

Study contacts

Contact information is provided by the study sponsor or research team.

Yi Zhang

CONTACT

[email protected]

+86 15639790587

Sponsors and collaborators

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Other

Registry information

Official study title

Clinical Study of Moxibustion in the Treatment of Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Feb 5, 2024
Registry last updated
Jul 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.